SE8404869L - 1,2,4-triazolonforeningar med antidepressiv aktivitet - Google Patents

1,2,4-triazolonforeningar med antidepressiv aktivitet

Info

Publication number
SE8404869L
SE8404869L SE8404869A SE8404869A SE8404869L SE 8404869 L SE8404869 L SE 8404869L SE 8404869 A SE8404869 A SE 8404869A SE 8404869 A SE8404869 A SE 8404869A SE 8404869 L SE8404869 L SE 8404869L
Authority
SE
Sweden
Prior art keywords
triazolone compounds
antidepressive activity
antidepressive
compounds
activity
Prior art date
Application number
SE8404869A
Other languages
English (en)
Other versions
SE8404869D0 (sv
SE465928B (sv
Inventor
R E Gammans
D W Smith
J P Yevich
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24145128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8404869(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8404869D0 publication Critical patent/SE8404869D0/sv
Publication of SE8404869L publication Critical patent/SE8404869L/sv
Publication of SE465928B publication Critical patent/SE465928B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE8404869A 1983-09-30 1984-09-28 1,2,4-triazolonfoereningar med antidepressiv aktivitet, foerfarande foer framstaellning av dessa och en farmaceutisk komposition SE465928B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/538,027 US4613600A (en) 1983-09-30 1983-09-30 Antidepressant 1,2,4-triazolone compounds

Publications (3)

Publication Number Publication Date
SE8404869D0 SE8404869D0 (sv) 1984-09-28
SE8404869L true SE8404869L (sv) 1985-03-31
SE465928B SE465928B (sv) 1991-11-18

Family

ID=24145128

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404869A SE465928B (sv) 1983-09-30 1984-09-28 1,2,4-triazolonfoereningar med antidepressiv aktivitet, foerfarande foer framstaellning av dessa och en farmaceutisk komposition

Country Status (25)

Country Link
US (1) US4613600A (sv)
JP (1) JPS60100560A (sv)
KR (1) KR880002624B1 (sv)
AT (1) AT387963B (sv)
AU (1) AU561460B2 (sv)
BE (1) BE900714A (sv)
CA (1) CA1237723A (sv)
CH (1) CH661924A5 (sv)
CY (1) CY1541A (sv)
DE (1) DE3435745C2 (sv)
DK (1) DK169546B1 (sv)
ES (1) ES536286A0 (sv)
FI (1) FI83310C (sv)
FR (1) FR2552759B1 (sv)
GB (1) GB2147297B (sv)
GR (1) GR80475B (sv)
HK (1) HK37391A (sv)
IE (1) IE58084B1 (sv)
IT (1) IT1178522B (sv)
LU (1) LU85561A1 (sv)
MY (1) MY102123A (sv)
NL (1) NL8402946A (sv)
SE (1) SE465928B (sv)
YU (1) YU45667B (sv)
ZA (1) ZA847589B (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US5504086A (en) * 1989-10-17 1996-04-02 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US6403593B1 (en) 1995-07-14 2002-06-11 Abbott Laboratories Triazole compounds and the use thereof
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
ES2262515T3 (es) 1999-04-09 2006-12-01 Sepracor Inc. R-hidroxinefazodona.
JP2002541192A (ja) 1999-04-09 2002-12-03 セプラコール， インク． Ｓ−ヒドロキシネファゾドン
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2567249A1 (en) * 2004-04-19 2006-10-05 Jds Pharmaceuticals, Llc Lithium combinations, and uses related thereto
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US9339500B2 (en) * 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
US9072660B2 (en) 2011-09-09 2015-07-07 The Board Of Trustees Of The Leland Stanford Junior University Topical itraconazole formulations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Also Published As

Publication number Publication date
HK37391A (en) 1991-05-24
DK468284D0 (da) 1984-09-28
FR2552759B1 (fr) 1988-10-07
FI83310B (fi) 1991-03-15
DE3435745C2 (de) 1994-11-03
BE900714A (fr) 1985-03-28
CY1541A (en) 1991-03-22
US4613600A (en) 1986-09-23
FI843779A0 (fi) 1984-09-26
JPH0542435B2 (sv) 1993-06-28
CH661924A5 (de) 1987-08-31
ES8601966A1 (es) 1985-11-16
AU561460B2 (en) 1987-05-07
MY102123A (en) 1992-03-31
IT1178522B (it) 1987-09-09
ES536286A0 (es) 1985-11-16
ATA310884A (de) 1988-09-15
FI843779L (fi) 1985-03-31
AT387963B (de) 1989-04-10
LU85561A1 (fr) 1985-06-04
FR2552759A1 (fr) 1985-04-05
NL8402946A (nl) 1985-04-16
SE8404869D0 (sv) 1984-09-28
IE842476L (en) 1985-03-30
FI83310C (sv) 1991-06-25
GR80475B (en) 1985-01-31
DE3435745A1 (de) 1985-04-11
KR880002624B1 (ko) 1988-12-07
GB8424535D0 (en) 1984-11-07
GB2147297B (en) 1987-04-15
SE465928B (sv) 1991-11-18
JPS60100560A (ja) 1985-06-04
IE58084B1 (en) 1993-06-30
IT8422922A0 (it) 1984-09-28
DK169546B1 (da) 1994-11-28
YU45667B (sh) 1992-07-20
ZA847589B (en) 1985-05-29
CA1237723A (en) 1988-06-07
DK468284A (da) 1985-03-31
GB2147297A (en) 1985-05-09
KR850002270A (ko) 1985-05-10
AU3364884A (en) 1985-04-04
YU172184A (en) 1986-10-31

Similar Documents

Publication Publication Date Title
SE8404869L (sv) 1,2,4-triazolonforeningar med antidepressiv aktivitet
NL7904528A (nl) Nieuwe n-aryloxazolidinonen, oxazolidinethionen, pyrro- lidinonen, pyrrolidinen en thiazolidinonen.
DE485170T1 (de) Verwendung von menthon-ketalen als aromaverstaerker.
EA200100058A1 (ru) 4-бензилпиперидиналкилсульфоксидные гетероциклические соединения и их применение в качестве подтип-избирательных антагонистов nmda-рецепторов
EA199800909A1 (ru) Тригидрат мезилата 5-(2-(4-(1,2-бензизотиазол-3-ил)пиперазин-1-ил)этил)-6-хлор-1,3-дигидро-2н-индол-2-она, фармацевтическая композиция и способ лечения психического расстройства
DE60128457D1 (de) 1,5-DISUBSTITUIERTE 3,4-DIHYDRO-1H-4,5-DöPYRIMIDIN-2-ON-VERBINDUNGEN UND IHRE VERWENDUNG IN DER BEHANDLUNG VON DURCH CSBP/P38 KINASE BEEINFLUSSTEN KRANKHEITEN
NO154345C (no) Analogifremgangsmaate for fremstilling av kardiotonisk virksomme 5-(pyridinyl)-2(1h)-pyridinoner.
PT77735B (fr) Procede de preparation de derives de benzoxazolinone
SE8600174L (sv) Nytt forfarande for framstellning av n-(2-pyrimidinyl)-piperazinylalkylazaspiroalkandioner
CY1106993T1 (el) Παραγωγα αζολινης
ATE240321T1 (de) 4- (thien-3-yl)methyl) imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität
KR900000343A (ko) 부텐 또는 프로펜 산 유도체
DE69106199T2 (de) Heterocyclische Acetonitrile und ihre Verwendung als Fungizide.
FI821739A0 (fi) 1-(3-halogen-2-pyridinyl)piperazin
ATE33648T1 (de) 1-(4-(benzothia- oder -oxazol-2-ylthio- oder -2- yloxy) phenyl>-1,3,5-triazin-2,4,6(1h,3h,5h)trione, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
FI861949A0 (fi) 2,4-difenyl-1,3-dioxaner.
KR960016716A (ko) 테트라졸리논
ATE2253T1 (de) Pyrimido und imidazo-pyrido-indol-dione, ihre herstellung und therapeutische verwendung.
DE58903912D1 (de) Verwendung von 2-substituierten ethansulfonverbindungen als galvanotechnische hilfsstoffe.
DE60103129D1 (de) Benzofurancarboxamide und deren therapeutische verwendung
ATE15894T1 (de) Heterocyclische derivate von amidoxinen, ihre herstellung und therapeutische verwendung.
ES536968A0 (es) Procedimiento para la preparacion de un nuevo derivado de 2-tolil-morfolina util en terapeutica
AR215290A1 (es) Procedimiento para la preparacion de 3-(4-(2:-piridil)-piperazin-1-il)-1-(3,4,5-trimetoxi-benzoiloxi)-propano y sus sales farmaceuticamente aceptables
ATE28865T1 (de) Benzoylharnstoff-verbindungen als schaedlingsbekaempfungsmittel.
DE3270566D1 (de) 4-aminomethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8404869-3

Format of ref document f/p: F

NUG Patent has lapsed